Malawi is based on the public health approach, with principles and practices borrowed from the successful DOTS (directly observed treatment, short course) tuberculosis control framework. The key principles include political commitment, free care, and standardized systems for case finding, treatment, recording and reporting, and drug procurement. Scale-up of ART started in June 2004, and by December 2008, 223,437 patients were registered for treatment within a health system that is severely underresourced. The Malawi model for delivering lifelong ART can be adapted and used for managing patients with chronic noncommunicable diseases, the burden of which is already high and continues to grow in low-income and middle-income countries. This article discusses how the principles behind the successful Malawi model of ART delivery can be applied to the management of other chronic diseases in resource-limited settings and how this paradigm can be used for health systems strengthening.
A very poor landlocked country in southern Africa, Malawi, has a per capita gross domestic product of less than US $200 per year, a population of 13 million 1 , and a dire HIV epidemic. In 2004, when antiretroviral therapy (ART) was being introduced at national scale, approximately 930,000 people were thought to be HIV infected, with another 100,000 new HIV infections occurring annually, and 170,000 people were estimated to be in immediate need of ART. At that time, 9 health facilities in the public sector delivered ART to about 3000 patients. ART delivery was unstructured, very few health care workers had been formally trained for the activity, and national systems of monitoring or reporting did not exist. In short, what might be called ''ART anarchy'' prevailed.
With the assistance of a well thought out national plan, explicit national guidelines for the management and monitoring of ART, and a standardized process for training health care workers and preparing facilities for ART, this life-saving treatment was scaled up rapidly and efficiently in both public and private sectors. By December 31, 2008 (4½ years after the start of scale-up), 170 health facilities in the public health sector had registered 215,449 adults and children on ART, and 51 health facilities in the private sector registered 7988 adults and children on ART. 3 Both public and private health sectors use the same standardized systems of delivering and monitoring treatment. By December 31, 2008, of the 223,437 patients ever registered in both public and private sectors, 147 479 (66%) were known to be alive and on ART, 23,699 (11%) were dead, 24,409 (11%) were lost to follow-up, 27,069 (12%) had transferred out to another treatment facility, and 781 patients were known to have stopped treatment. The number of new patients registered increased year by year, from 10,183 in 2004 to 76,581 in 2008. 3 Although technical and operational challenges remain in abundance, this growth has been, and continues to be, an immense achievement for Malawi and an oft-cited example internationally. ART has already begun to reduce adult mortality at the population level. 4 This article discusses how the principles behind the successful Malawi model of scaling up ART can be applied to the management of other chronic diseases in resourcelimited settings and how this paradigm can be used for health systems strengthening.
PRINCIPLES OF ART SCALE-UP IN MALAWI AND REASONS FOR SUCCESS
Right from the start it was recognized that ART delivery in Malawi using a ''medicalized'' model would not work and that the key to rapid and massive scale-up was to keep the principles and practices of ART delivery as simple as possible. In this regard, many of the principles of DOTS (directly observed treatment, short course)-the system used to successfully deliver tuberculosis (TB) treatment to people in some of the world's poorest countries 5 -were borrowed and adapted to ART delivery and could be similarly adapted for other chronic diseases (Box 1). A standardized system was put in place so that the same system of assessing patients for ART eligibility, initiating treatment, and registering and reporting cases and outcomes was followed wherever ART was being delivered from central hospital to health center and from public health facility to private clinic. An important policy decision was made that ART in the public sector was to be free to all patients and subsidized for patients in the private sector.
Of the number of factors responsible for the success of Malawi's ART scale-up, the most important were:
The clear lead taken by the Ministry of Health in assuming responsibility for national scale-up and a desire by all implementing partners to work with the Ministry of Health and use nationally standardized systems. A focus on scaling up using a single first-line fixed-dose combination regimen, a focus that was made possible by the fact that Malawi's sole ART funding source was the Global Fund. The existence of clear national ART guidelines, with an emphasis also placed on the system of registration, monitoring, and recording of results. 6, 7 An intensive training schedule focused particularly on clinical officers and nurses learning ART guidelines and undertaking practical attachments at experienced ART sites. A structured system of accrediting ART sites before they were permitted to deliver treatment to patients. Quarterly supervision and monitoring and reporting for all ART delivery sites by the HIV Unit of the Ministry of Health and its partners. An absence of ARV drug stockouts.
Because of this simplified and highly standardized delivery model, an average of approximately 1 clinician and 1 nurse were able to manage 1000 patients on ART by the end of 2008. 3 
ADAPTING THE ANTIRETROVIRAL DELIVERY MODEL TO MANAGEMENT OF OTHER CHRONIC DISEASES
The prevalence and incidence of noncommunicable diseases (NCDs) such as hypertension, diabetes mellitus, cardiovascular disease, obstructive airways disease, and asthma grow inexorably each year and increasingly affect patients and communities in resource-poor settings. 8 For example, diabetes mellitus was estimated to affect 246 million people globally in 2007, with 6 million new cases and 3.5 million deaths; 70% of this burden was in developing countries. 9 Similar numbers pertain to asthma: 300 million patients are estimated to be living with the disease, with 250,000 deaths annually-the majority in developing countries. 10 Even in rural communities in southern Africa, racked by chronic infectious diseases such as HIV/AIDS and TB, the burden and mortality of chronic NCDs such as cardiovascular disease, diabetes, and malignancy increases year by year.
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Although patients with these NCDs usually need chronic care and treatment over their lifetimes, it is simply not provided in most resource-poor countries outside a few centers of excellence, and there are no systems to monitor patient access or outcomes. The system put in place in Malawi to facilitate the management and monitoring of lifelong ART can also be used for patients with NCDs. 12 Simple diagnostic and treatment protocols would be helpful for patients in chronic structured care to ensure that standard quality treatment is maintained at all levels of the health care system. Primary outcomes-alive, dead, stopped therapy, lost to follow-up, and transferred out to another treatment facility-apply to all NCDs. Quarterly collation of data would allow regular updating of the denominator (how many patients have started on therapy in a facility) and the key numerator (how many patients are retained on therapy in that facility at the end of every quarter). The number of patients alive and on treatment can be further subdivided into those on particular types of medication and those with complications of the disease. The number alive and on treatment is a vital piece of strategic information, which provides at any set moment in time the prevalent number of cases and thus the current burden of disease. If measured regularly and accurately, this information would be vital for rational drug forecasting and planning of logistics and staffing.
BOX 1. Principles of TB Control

USING CHRONIC DISEASE MANAGEMENT PARADIGMS FOR STRENGTHENING HEALTH SYSTEMS
Implementation of any system that seeks to provide and monitor special quality care for patients with chronic infectious and noninfectious diseases on a large scale must be sensitive to the needs of the general health sector, as otherwise there is a risk of setting up multiple parallel, or ''vertical,'' programs. This being said, many urban hospitals in developing countries already run special clinics for patients with diabetes mellitus, hypertension, or asthma. Consideration could be given to merging these into single clinics for chronic diseases as in hospitals and health centers in Cambodia, 13 where ART, diabetes, and hypertension have been successfully managed together, and in rural centers in Ethiopia, 14 where diabetes and epilepsy are managed together. Moreover, efforts to reduce mother-to-child transmission of HIV should be seen not as stand-alone interventions but rather as an integral component of maternal and child health.
For all clinics serving special populations, regular structured supervision is needed to ensure that monitoring systems are of good quality, but these supervisory activities can be developed and expanded to benefit the wider health sector and chronic diseases. There is a growing conviction that vertical programs can be adapted to drive improvements throughout the health system, particularly in hitherto weak areas such as laboratory infrastructure and service delivery, monitoring, supervision, quality assurance, and rational drug forecasting and procurement. 15 Any attempt to better the management and monitoring of special diseases must include a vision of how the work will improve the health sector and health care delivery as a whole.
CONCLUSIONS
The provision and monitoring of ART to thousands of patients living in resource-poor countries like Malawi, based on the DOTS framework for TB control developed during the mid-1990s, 5 can serve as a model for managing and monitoring the growing burden of NCDs. Malawi's ART scale-up was based on a strategy, guidelines, and a well thought out plan, but the implementation was all about learning while doing. The same principles can be applied to the management of NCDs, with a vision and a strategy about how to move forward and operational research used to work out and refine the all-important details.
